Programmed cell death ligand (PD-L1) is usually overexpressed on various cancer cells and, combined with programmed cell death protein 1 (PD-1; CD279), which is overexpressed on activated T cells, enables the immune evasion of cancer cells. The gene discussed is PDCD1; the disease is cancer.